Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 26, 2011
Dr. Steven J. O'Day, Director, Melanoma Research at The Angeles Clinic and Research Institute had good news for melanoma suffers. At the second annual Melanoma Education Symposium in Culver City, CA Saturday (3/26/11), Dr. O'Day discussed a new drug named Ipilimumab that is actually targeting the patient's own immune system to fight malignant tumors.